Based on the company's latest reports for March 2025, the current 12-month EPS is $4.53. Zimmer Biomet Holdings's earnings per share in 2024 was reported at $4.45, marking a decline from $4.91 in 2023. In the quarterly report ending on Mar 31, 2025, ZBH's earnings per share amounted to $0.92.
Zimmer Biomet Holdings had an yealy earnings per share of $4.45, showing a decline of 9.4% from $4.91 recorded in 2023. The quarterly earnings per share for the period ending Mar 31, 2025, was $0.92, showing a 9.5% increase compared to the same quarter last year. The trailing twelve months EPS for ZBH is $4.53 as of March 2025. Zimmer Biomet Holdings's full-year EPS for 2023 was $4.91, a 346.4% rise compared to the previous year.
Zimmer Biomet Holdings has recorded a growth in earnings per share of 9.5% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 32.1% per year. Zimmer Biomet Holdings had an average annual EPS growth of -4.2% in the last five years. When assessed over a ten-year period, ZBH's average EPS annual growth was 0.4%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
EW Edwards Lifesciences Corp | 10.93 | 202.2% | 42.5% | 33% |
ZBH Zimmer Biomet Holdings Inc | 20.76 | -9.4% | 32.1% | -4.2% |
COO Cooper Companies Inc | 34.71 | 32.2% | -49.1% | -3.5% |
SYK Stryker Corp | 52.08 | -5.8% | 14.1% | 7.1% |
BSX Boston Scientific Corp | 74.99 | 16.7% | 22.2% | -17.9% |
All data is based on quarterly TTM periods, unless otherwise specified.